The human C-type lectin 18 is a potential biomarker in patients with chronic hepatitis B virus infection.

Tsung-Yu TsaiCheng-Yuan PengHwai-I YangYa-Lang HuangMi-Hua TaoShin-Sheng YuanHsueh-Chou LaiShie-Liang Hsieh

Published in: Journal of biomedical science (2018)

Plasma CLEC18 levels were correlated with the stage of HBV infection and could predict HBeAg loss and seroconversion in the patients with CHB undergoing NUC therapy.

Keyphrases

hepatitis b virus
endothelial cells
induced pluripotent stem cells
liver failure
pluripotent stem cells
stem cells
smoking cessation
replacement therapy